Cancer biomarkers circulating in body fluids can be used for diagnosis and treatment monitoring. However, current detection technology lacks the required sensitivity, limiting biomarker use in clinical applications.
Colorectal cancer is the second most common cancer in Europe with respect to incidence and mortality. Although early detection significantly improves outcome, screening compliance in the wider population is low due to the invasive nature of the colonoscopy procedure.
To facilitate prompt cancer diagnosis, the EU-funded ULTRAPLACAD project developed an in vitro platform for the detection of cancer nucleic acid and protein biomarkers circulating in the blood. “The idea was to improve biomarker detection sensitivity by a factor of 1 000, reduce the cost four-fold and the analysis time down to 1 hour,″ explains project coordinator Prof. Giuseppe Spoto of the University of Catania in Italy. The project team involved 13 partners across Europe with cross-disciplinary competencies, including pioneers in surface plasmon resonance.
Innovative technologies
The ULTRAPLACAD device has been designed to integrate a microfluidic circuit with functionalised nanostructure chips. It combines nanostructure-enhanced surface plasmon resonance imaging (NESPRI) and plasmon-enhanced fluorescence spectroscopy imaging (PEFSI). These two novel sensing technologies provide ultrasensitive detection and reduce the need for sample chemical modifications.
Chip design, surface architecture and chemical functionalisation of nanostructures facilitate the simultaneous measurement of multiple markers. For efficient nucleic acid detection, such as Ras mutations and miRNAs, specific probes have been synthesised. The disposable chips are mass produced through an automated fabrication process, which brings down the cost of the assay.
Traditionally, detection of minute amounts of DNA released in body fluids by tumour cells necessitates a pre-amplification step by polymerase chain reaction. The novelty of ULTRAPLACAD lies in the detection assays that do not require enzymatic amplification of DNA in liquid biopsies, thereby avoiding potential errors.
A bimodal reader for NESPRI and PEFSI technologies makes the ULTRAPLACAD device unique and improves the overall detection process even further. As Dr Spoto emphasises “the main advantage of the device is that it can detect both nucleic acids and protein using one single equipment operating with disposable chips.″
The ULTRAPLACAD prototype has been validated using animal models and samples from colorectal cancer patients. Results demonstrate that the sensitivity of the device exceeds conventional detection platforms and the whole assay is faster and simpler in its implementation.
The future of ULTRAPLACAD
Undoubtedly, the combined detection of cancer DNA sequences and selected tumour autoantibodies provide an effective cancer detection approach. ULTRAPLACAD offers a unique platform that can detect both DNA and protein cancer biomarkers, simplifying the process of diagnosis and patient follow-up.
Considering the limitations of existing colorectal cancer screening choices, ULTRAPLACAD offers a non-invasive alternative solution for average-risk asymptomatic people. As such, it will reduce the number of invasive procedures, cut down healthcare costs, and improve patient compliance and management.
Although the platform was specifically fabricated for early diagnosis and prognosis of colorectal cancer, its application can extend to other types of cancer. Long-term, it is also expected to determine the molecular heterogeneity of individual tumours, helping disease stratification and personalised therapy. In view of the future, Prof. Spoto envisages “the ULTRAPLACAD device will contribute to revolutionise molecular diagnosis of cancer and make a difference in cancer care.″
News
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
